Viome Life Sciences has partnered with Microsoft to integrate AI-powered RNA-based molecular diagnostics into personalized healthcare. This collaboration leverages Viome's gene expression data combined with Microsoft's Azure infrastructure to advance proactive home-based health solutions. By analyzing human and microbial RNA from various samples, the integrated platform aims to detect early molecular signs of inflammation and chronic disease, enhancing preventive care capabilities. The partnership represents a significant joint effort to harness AI and cutting-edge biology for impactful healthcare innovation.